Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.24.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenues $ 1,517 $ 5,906 $ 3,053 $ 8,082
Cost of goods sold 310 767 588 1,866
Gross loss 1,207 5,139 2,465 6,216
Operating expenses:        
General and administrative 203,242 142,464 552,874 907,595
Professional fees 169,596 236,139 971,934 413,651
Depreciation expense 9,274 25,578
Total operating expenses 372,838 387,877 1,524,808 1,346,824
Operating loss (371,631) (382,738) (1,522,343) (1,340,608)
Other income (expense):        
Gain (loss) on early extinguishment of debt (724,086) 4,397
Loss on deconsolidation of foreign subsidiaries (22,359) (242,631)
Interest income 3 6
Interest expense (340,609) (67,571) (811,620) (177,169)
Total other expense (362,968) (67,568) (1,778,337) (172,766)
Net loss (734,599) (450,306) (3,300,680) (1,513,374)
Other comprehensive loss:        
Gain (loss) on foreign currency translation (32,831) (42,328) 145,370
Net other comprehensive loss (734,599) (483,137) (3,343,008) (1,368,004)
Series A convertible preferred stock declared ($0.60 per share) (15,083) (15,083) (44,915) (43,808)
Net loss attributable to common shareholders $ (749,682) $ (498,220) $ (3,387,923) $ (1,411,812)
Weighted average number of common shares outstanding - basic 113,618,305 74,958,373 104,404,946 71,436,129
Weighted average number of common shares outstanding - diluted 113,618,305 74,958,373 104,404,946 71,436,129
Net loss per share - basic $ (0.01) $ (0.01) $ (0.03) $ (0.02)
Net loss per share - diluted (0.01) (0.01) (0.03) (0.02)
Dividends declared per share of common stock $ 0.00 $ 0.00 $ 0.00 $ 0.00